Lv1
36 积分 2022-06-21 加入
INDIRECT TREATMENT COMPARISON OF TEZEPELUMAB VERSUS OTHER BIOLOGICS IN SEVERE CHRONIC RHINOSINUSITIS WITH NASAL POLYPS
7天前
已关闭
Tissue-based map of the human proteome
9天前
已完结
Tezepelumab in Real-World U.S. Patients with Severe Asthma Across Phenotypes and Underrepresented Populations: The Phase 4 PASSAGE Study
16天前
已完结
Epithelial alarmins: a new target to treat chronic respiratory diseases
26天前
已完结
Clinical efficacy and mechanisms of biologics for chronic rhinosinusitis with nasal polyps
1个月前
已完结
New Concepts in Barrier Dysfunction in CRSwNP and Emerging Roles of Tezepelumab and Dupilumab
1个月前
已完结
Current Understanding of Epithelial-Derived Alarmins in Chronic Rhinosinusitis with Nasal Polyps
1个月前
已完结
Small airway dysfunction and glucocorticoid (OCS) reduction in severe asthma: Clinical insights from real-world tezepelumab use
2个月前
已完结
Small airway dysfunction and glucocorticoid (OCS) reduction in severe asthma: Clinical insights from real-world tezepelumab use
2个月前
已完结
Tezepelumab Reduces Alarmin Cytokine Levels in Upper Airway Epithelial Cells in Patients With Severe Asthma
2个月前
已完结
皖公网安备34019202002308
